性类固醇对老年男性认知的影响
Carolina C B Caetano1, Sami Liberman1, Jéssica M L Ie2
1Disciplina de Geriatria, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo, Brazil)
|March 1, 2026
概括
在老年男性中,较低的丸激素水平与抑郁症相关,但与整体认知功能无关. 多年的教育显著影响了认知表现,根据迷你精神状态检查 (MMSE) 的测量.
科学领域:
- 老年学是一门学科.
- 神经内分泌学神经内分泌学
- 认知科学 认知科学
背景情况:
- 对于认知发育和基于性别的行为差异至关重要.
- 与年龄相关的丸激素下降对老年男性认知功能的影响尚不清楚.
研究的目的:
- 调查血清类固醇激素水平与老年男性认知功能之间的关系.
- 为了确定丸激素是否影响老年男性的认知表现.
主要方法:
- 60名老年男性 (平均年龄为73.5岁) 通过迷你精神状态检查 (MMSE) 和老年抑郁量表 (GDS) 进行认知评估.
- 测量了总体 (TT),自由 (FT),雌激素 (E2) 和性激素结合型球蛋白的血清水平.
- 统计分析,包括非参数测试和多变量回归,用于将激素水平与认知和抑郁症得分相关联.
主要成果:
- 年龄与总丸激素 (TT) 有负相关.
- 身体质量指数 (BMI) 与MMSE总分数负相关.
- TT和自由 (FT) 与老年抑郁量表 (GDS) 评分有负相关性,这表明较低的和抑郁症状之间存在联系.
- 经过调整后,只有教育年数与MMSE成绩保持独立关联.
结论:
- 老年男性血清丸激素水平较低与抑郁症状有关,但与全球认知表现无关.
- 在这一群体中,多年的教育成为认知功能的重要独立预测因素 (MMSE分数).
- 需要进一步的研究才能充分阐明激素,衰老和认知之间的复杂相互作用.
更多相关视频
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:30Cognitive Development During Adulthood
999
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
999
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:28Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
751
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
751
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273